ResMed Aktie
231,10
EUR
-10,70
EUR
-4,43
%
236,31
USD
-21,25
USD
-8,25
%
Werbung
ResMed Aktie Analyse
25.09.17 | ResMed Underweight | Barclays Capital | |
07.04.16 | ResMed Underweight | Barclays Capital | |
27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung